Last reviewed · How we verify
NCT03793959
How Does a Synbiotic Supplement Affect Iron Status During Iron Repletion in Iron Depleted Female Athletes?
NA trial testing Synbiotic Supplement in Iron-deficiency in 20 participants. Completed in 8 December 2017.
8 December 2017
Quick facts
| Lead sponsor | Marywood University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 28 August 2016 |
| Primary completion | 8 December 2017 |
| Estimated completion | 8 December 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Synbiotic Supplement — full drug profile →
- Placebo
Conditions studied
- Iron-deficiency — all drugs for Iron-deficiency →
Sponsor
Marywood University
Who can join
18 and older, female only, with Iron-deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Iron deficiency (ID) affects \~30% of female athletes, and its consequences are highly relevant to athletic performance. Poor iron (Fe) uptake remains a major factor in the development of ID. While animal studies suggest that prebiotics may improve Fe uptake, this has not been well-studied in humans. The main objective of the proposed study is to determine the effects of synbiotic supplementation on the Fe status of ID female athletes during Fe repletion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03793959
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Synbiotic Supplement
Trials testing the same drug.
- NCT07430280 — Synbiotic Supplementation and Inflammation in Predialysis Chronic Kidney Disease · NA · not yet recruiting
- NCT07342946 — The Effects of the Mediterranean Diet and Synbiotics in Polycystic Ovary Syndrome · NA · not yet recruiting
- NCT06746285 — Evaluating the Impact of Synbiotic Supplementation on Infants and Toddlers · NA · active not recruiting
- NCT03455192 — Synbiotic as an Adjunct to Mechanical Treatment of Gingivitis · NA · completed
Other recruiting trials for Iron-deficiency
Currently open trials in the same condition.
- NCT05407987 — Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) · Phase 3 · recruiting
- NCT06270498 — Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure · Phase 4 · recruiting
- NCT05913414 — Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT05340465 — Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants · Phase 2 · recruiting
- NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03793959 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marywood University
- Last refreshed: 4 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03793959.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing